✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals

Fischer Medical Ventures Ltd.

FISCHER

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,071 Cr.
P/E
154.17

Fischer Medical Ventures Ltd.

  • Fischer Medical
  • Tatva Chintan Pharma
  • Rossari Biotech

FAQs on Fischer Medical Ventures Ltd. Shareprice

Fischer Medical has given better returns compared to its competitors.
Fischer Medical has grown at ~57.63% over the last 4yrs while peers have grown at a median rate of 3.89%

Fischer Medical is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Fischer Medical is 161, while 3 year average PE is 19.69.
Also latest EV/EBITDA of Fischer Medical is 135 while 3yr average is 5387.

View FAQ's On Business

Growth Table

  • Fischer Medical Ventures Ltd.
  • Tatva Chintan Pharma
  • Rossari Biotech

Balance Sheet

  • Fischer Medical Ventures Ltd.
  • Tatva Chintan Pharma
  • Rossari Biotech

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Fischer Medical Ventures Ltd.
  • Tatva Chintan Pharma
  • Rossari Biotech

Cash Flow

  • Fischer Medical Ventures Ltd.
  • Tatva Chintan Pharma
  • Rossari Biotech

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Fischer Medical Ventures Ltd.
  • Tatva Chintan Pharma
  • Rossari Biotech

Quarterly Results

  • Fischer Medical Ventures Ltd.
  • Tatva Chintan Pharma
  • Rossari Biotech

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Fischer Medical Ventures Ltd. Financials

Balance sheet of Fischer Medical is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Fischer Medical is increasing.
Latest net debt of Fischer Medical is -₹27.6 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹442.31 Crs.

Yes, profit is increasing.
The profit of Fischer Medical is ₹20.19 Crs for TTM, ₹1.48 Crs for Mar 2025 and ₹1.38 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Fischer Medical latest dividend payout ratio is 21.53% and 3yr average dividend payout ratio is 21.53%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech